Picture of Coherus Biosciences logo

CHRS Coherus Biosciences Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Annual balance sheet for Coherus Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Cash and Short Term Investments12772.4178541417
Net Total Accounts Receivable
Net Total Receivables0142157123
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets14584.4343767602
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment12.86.6616.520.116
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets16399.5409842679
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities28.433.3115146165
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities131138304561582
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity31.8-38.610528197.7
Total Liabilities & Shareholders' Equity16399.5409842679
Total Common Shares Outstanding

Or unlock with your email

Or unlock with your email